The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents

Shranjeno v:
Bibliografske podrobnosti
izdano v:Haematologica
Main Authors: Tarantelli, Chiara, Zhang, Lu, Curti, Elisabetta, Gaudio, Eugenio, Spriano, Filippo, Priebe, Valdemar, Cascione, Luciano, Arribas, Alberto J., Zucca, Emanuele, Rossi, Davide, Stathis, Anastasios, Bertoni, Francesco
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2019
Teme:
Online Only Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6601092/
https://ncbi.nlm.nih.gov/pubmed/30679329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.214759
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki